62 Ventures

Overview

62 Ventures is a Chicago-based venture capital firm dedicated to investing in innovative healthcare companies that aim to improve patient outcomes and reduce costs. The firm focuses on early-stage businesses, providing funding from pre-seed through Series C stages. With a global perspective, 62 Ventures primarily invests in companies headquartered in the United States, India, and the Middle East. The firm typically writes checks between $1 million and $10 million and is open to both leading and co-investing in funding rounds. Led by serial entrepreneur Glen Tullman, CEO of Transcarent and Co-Founder & Managing Partner of 7wireVentures, 62 Ventures brings over 30 years of experience in scaling early-stage companies and building category-defining businesses. The firm's investment strategy emphasizes backing companies that leverage technology to disrupt large industries and create new categories, particularly in sectors such as health and care, education, and environmental sustainability. 62 Ventures takes pride in its portfolio companies, including Khyaal, a super-app for senior citizens in India, and Loop Health, a health insurance broker that integrates primary care physicians, specialty networks, and health insurers under one roof. These investments reflect the firm's commitment to supporting businesses that deliver exceptional customer value and drive positive social impact through innovation and adaptability.

Investment Focus

• Innovative solutions in healthcare
• Focus on improving patient outcomes
• Commitment to reducing healthcare costs
• Adaptability and positive mindset
• Redefining traditional industries
• Delivering exceptional customer value

Portfolio Companies